Literature DB >> 19789203

Somatostatin receptor expression in an epitheloid hemangioma causing oncogenic osteomalacia.

Karsten Müssig1, Mehmet Ozer Oksüz, Christina Pfannenberg, Patrick Adam, Jozef Zustin, Stefan Beckert, Stephan Petersenn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19789203     DOI: 10.1210/jc.2009-0927

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  6 in total

Review 1.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

2.  Tumor-induced osteomalacia: experience from a South American academic center.

Authors:  G González; R Baudrand; M F Sepúlveda; N Vucetich; F J Guarda; P Villanueva; O Contreras; A Villa; F Salech; L Toro; L Michea; P Florenzano
Journal:  Osteoporos Int       Date:  2017-03-25       Impact factor: 4.507

3.  Osteomalacia caused by tumors in facies cranii mimicking rheumatoid arthritis.

Authors:  Wang Xian-Ling; Ba Jian-Ming; Zhong Wen-Wen; Lü Zhao-Hui; Dou Jing-Tao; Lu Ju-Ming; Mu Yi-Ming
Journal:  Rheumatol Int       Date:  2011-07-26       Impact factor: 2.631

4.  Twins in spirit part II: DOTATATE and high-affinity DOTATATE--the clinical experience.

Authors:  Claudia Brogsitter; Klaus Zöphel; Holger Hartmann; Margret Schottelius; Hans-Jürgen Wester; Jörg Kotzerke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-15       Impact factor: 9.236

5.  Ga-68 DOTATATE Positron Emission Tomography-Computed Tomography Imaging in Oncogenic Osteomalacia: Experience from a Tertiary Level Hospital in South India.

Authors:  Junita Rachel John; Julie Hephzibah; Regi Oommen; Nylla Shanthly; David Mathew
Journal:  Indian J Nucl Med       Date:  2019 Jul-Sep

6.  Tumor-induced osteomalacia.

Authors:  Pablo Florenzano; Rachel I Gafni; Michael T Collins
Journal:  Bone Rep       Date:  2017-09-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.